These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2861646)
1. [Treatment of ulcer: a single dose of anti-H2]. Loizeau E Rev Med Suisse Romande; 1985 Apr; 105(4):281-2. PubMed ID: 2861646 [No Abstract] [Full Text] [Related]
2. [H2 blockers in the treatment of bleeding gastroduodenal ulcers]. Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821 [No Abstract] [Full Text] [Related]
3. [Treatment of uncomplicated duodenal ulcer with an antacid-containing attapulgite. Effectiveness and tolerance in comparison with a H2 receptor antagonist]. Mayer R; Sack W; Wagner W Fortschr Med; 1985 Dec; 103(45):1055-8. PubMed ID: 2867015 [No Abstract] [Full Text] [Related]
4. [Treatment of duodenal ulcer with famotidine]. Schütze K; Hentschel E; Reichel W; Kerstan E Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224 [TBL] [Abstract][Full Text] [Related]
5. A single nocte dose of famotidine in the treatment of duodenal ulcer. Qureshi H; Ahmad W; Zuberi SJ J Pak Med Assoc; 1989 Apr; 39(4):104-6. PubMed ID: 2568508 [TBL] [Abstract][Full Text] [Related]
6. [Famotidine treatment of patients with gastric and duodenal ulcers. A comparative study with once or twice-a-day administration]. Bonardelli P; Fujita Y; Fujita R; Sugata F Clin Ter; 1987 Aug; 122(3):183-7. PubMed ID: 2904317 [No Abstract] [Full Text] [Related]
8. [Which drug for peptic ulcer?]. Hameeteman W; Tytgat GN Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643 [No Abstract] [Full Text] [Related]
9. [Treatment of duodenal ulcer with rosaprostol in patients resistant to treatment with anti-H2]. Tincani GP; Maniscalco G; Gunelli M; Ciarrocchi V Minerva Med; 1987 Jun; 78(12):847-53. PubMed ID: 2885786 [TBL] [Abstract][Full Text] [Related]
10. [Current directions in the treatment of gastric and duodenal ulcers]. Fellus R Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566 [No Abstract] [Full Text] [Related]
11. [High demands on drug administration and pharmacological principles applied in ulcer diseases]. Hellström PM Lakartidningen; 1991 Feb; 88(6):425-30. PubMed ID: 1671887 [No Abstract] [Full Text] [Related]
12. [Therapeutic management of duodenal ulcer except in emergency: eradication of Helicobacter pylori]. Lamouliatte H Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S58-S63. PubMed ID: 8734372 [No Abstract] [Full Text] [Related]
13. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer. Thomas JM; Misiewicz G Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417 [No Abstract] [Full Text] [Related]
14. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220 [TBL] [Abstract][Full Text] [Related]
15. [Acid anti-secretion therapy in gastric and duodenal ulcer]. Lattanzi A Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184 [No Abstract] [Full Text] [Related]
17. Misoprostol and NSAID ulcers. Isaacs P Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480 [No Abstract] [Full Text] [Related]
18. The influence of relapse rate on the choice of duodenal ulcer therapy. Drug Ther Bull; 1987 Oct; 25(20):77-80. PubMed ID: 2890508 [No Abstract] [Full Text] [Related]